1). Do any of the hospital (s) in your Trust admit as daycase or longer patients who are admitted to undergo thyroid surgery?
2a) How many consultant surgeon(s) in your trust undertake thyroid surgery operations?
2b) What are the parent specialties of each of the surgeons undertaking thyroid surgery operations e.g. general surgery, endocrine surgery, otolaryngology, OMFS etc.
2c) In 2017 (1st Jan to 31st Dec 2017) how many thyroid operations procedures did each consultant surgeon undertake (include number undertaken by other team members where the patients were under the care of the consultant). Please break down also by parent specialty
2c) i) How many of the consultant surgeons undertaking thyroid surgery in your trust submit all or most of their thyroid patient outcome data to the United Kingdom Register of Thyroid and Endocrine Surgery (UKRETS) provided by British Association of Thyroid and Endocrine Surgery?
ii) Of this group what is the breakdown of their parent speciality(ies)
2d) With regard to the local Thyroid cancer MDT how many of the consultant surgeons undertaking thyroid surgery in your trust or other health service organisation are:
i) Core members of the local thyroid cancer MDT.
ii) Extended members of the local thyroid cancer MDT.
iii) Not connected with the local thyroid cancer MDT.
2e) Which Trust or other health service organisation and which hospital site hosts the local thyroid Cancer MDT that connected surgeons attend?
3) This question only applies if your Trust or other Health Service Organisation Hosts the local Thyroid MDT.
3a) What is the frequency of the local thyroid cancer MDT meeting?
3b) Is the MDT:
i)‘Stand alone ‘
ii) Adjacent in time to the Head and Neck MDT but not within the Head and Neck MDT
iii) Within the Head and Neck MDT.
iv) Other – please give details:
v) What medical / surgical / diagnostic specialties are represented in the CORE membership of the MDT (doctors only)
vi) What medical / surgical / diagnostic specialties are represented in the EXTENDED membership of the MDT (doctors only)
3c) Does the MDT Routinely discuss the following groups of patients?
i) Patients who are being investigated but have not yet had surgery but where pre operative investigation has shown a high likelihood of
ii) Patients who are being investigated but have not yet had surgery but where pre operative investigation has shown an intermediate risk of cancer
iii) Patients who have had thyroid surgery and where histopathology has shown thyroid cancer in the resected specimen?